Diagnostic utility of testing for antineutrophil cytoplasmic antibodies

Mukhtyar, Chetan B. (2022) Diagnostic utility of testing for antineutrophil cytoplasmic antibodies. Polskie Archiwum Medycyny Wewnetrznej, 132 (3). ISSN 0032-3772

[img]
Preview
PDF (inv_ed_Mukhtyar) - Published Version
Available under License Creative Commons Attribution Non-commercial Share Alike.

Download (91kB) | Preview

Abstract

Antineutrophil cytoplasmic antibodies (ANCA) that target the third neutral serine proteinase (PR3) and myeloperoxidase (MPO) of human neutrophils are associated with primary systemic vasculitis that predominantly affects small and medium blood vessels.1,2 There is an international consensus that testing for ANCA should specifically be focused on identifying antibodies against those 2 antigenic targets.3 In this edition of the journal, Wójcik et al4 discuss the data from the Polish Vasculitis Register (POLVAS) including information from 536 individuals who presented with vasculitis over 27 years, in the demographic context.

Item Type: Article
Uncontrolled Keywords: internal medicine ,/dk/atira/pure/subjectarea/asjc/2700/2724
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 11 Apr 2022 10:30
Last Modified: 10 May 2022 00:40
URI: https://ueaeprints.uea.ac.uk/id/eprint/84572
DOI: 10.20452/pamw.16224

Actions (login required)

View Item View Item